The biological mechanisms for the decreased risk of mortality from heart failure with higher concentrations of IGF biomarkers are not well-known; however, some suggestions are as follows: via endocrine, paracrine, and autocrine anabolic effects, the IGF-axis is involved in the cellular proliferation and growth of numerous tissues, including the heart. The gene discussed is IGF1; the disease is heart failure.